← Back to Clinical Trials
Recruiting NCT06886581

NCT06886581 Online Training Course to Improve Evidence-based Leadership

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06886581
Status Recruiting
Phase
Sponsor University of Turku
Condition Evidence-Based Practice
Study Type INTERVENTIONAL
Enrollment 300 participants
Start Date 2025-06-05
Primary Completion 2026-07-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Evidence-based leadership training

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 300 participants in total. It began in 2025-06-05 with a primary completion date of 2026-07-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this cluster clinical trial is to evaluate the effectiveness of online training course, targeted to unit leaders to improve staff's evidence-based skills (individual outcomes), EBP implementation (team-based outcomes), and the quality of care (organisational outcomes). Feasibility and fidelity of the intervention will be assessed as well. The main questions it aims to answer are: 1. Does online training course improve staff's evidence-based practice? 2. Does online training course improve staff's self-esteem and self-efficacy? 3. Does online training course improve leadership for EBP implementation on organisational level? 4. Does online training course improve the quality of patient care? 5. Does online training course reduce staff's absence (sick leaves, intention to leave the ward or hospital)? Participants will: * Participants will join in a seven-months online training course in small group or practice as usual. * Seven course modules, read course material, prepare assignments, join in peer discussions. * Self-assessment, self-reflection and give course feedback.

Eligibility Criteria

Inclusion Criteria: * have shown their willingness to join the study, * unit leaders have an official managerial position at the study organisation, * unit have a leaders with a professional licence to work in health or social care sector, * unit leaders represent any gender, * are able to speak, read and write in Finnish, and * have given informed consent to join the study. Exclusion Criteria: * Those staff members who are off duty during the recruitment period (family leave, long-term sick leave, study leave, or any other reason).

Contact & Investigator

Central Contact

Maritta A Välimäki, PhD

✉ maritta.valimaki@helsinki.fi

📞 +358-40-5599235

Principal Investigator

Maritta A Välimäki, PhD, Professor

PRINCIPAL INVESTIGATOR

University of Helsinki

Frequently Asked Questions

Who can join the NCT06886581 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Evidence-Based Practice. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06886581 currently recruiting?

Yes, NCT06886581 is actively recruiting participants. Contact the research team at maritta.valimaki@helsinki.fi for enrollment information.

Where is the NCT06886581 trial being conducted?

This trial is being conducted at Helsinki, Finland.

Who is sponsoring the NCT06886581 clinical trial?

NCT06886581 is sponsored by University of Turku. The principal investigator is Maritta A Välimäki, PhD, Professor at University of Helsinki. The trial plans to enroll 300 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology